中药干预HMGB1通路改善2型糖尿病及其并发症的研究进展

卢爱琳 ,  袁梦蕊 ,  吴永青 ,  刘弘毅

中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 827 -835.

PDF (1174KB)
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 827 -835. DOI: 10.12092/j.issn.1009-2501.2026.06.012

中药干预HMGB1通路改善2型糖尿病及其并发症的研究进展

作者信息 +

Progress of Chinese medicine intervention in HMGB1 pathway to im- prove type 2 diabetes mellitus and its complications

Author information +
文章历史 +
PDF (1201K)

摘要

2 型糖尿病(type 2 diabetes mellitus,T2DM)的发生与胰岛素抵抗和胰岛 β 细胞功能障碍密切相关,高迁移率族蛋白 B1(high mobility group box 1,HMGB1)及其调控的相关受体和信号通路在 T2DM 及其并发症的发生发展中具有重要作用。HMGB1 是炎症反应中的核心调节因子,广泛存在于肝脏、脂肪、骨骼肌以及胰岛等各类组织器官当中,主要通过增强炎症反应和加剧胰岛素抵抗等方式影响 T2DM 的病程。近年来,多种中药被证明可通过调控 HMGB1 及其相关受体和信号通路的表达,延缓 T2DM 及其并发症的进展。本文针对中药干预 HMGB1 通路改善 T2DM 及其并发症的国内外研究现状展开论述,旨在为未来运用中医药治疗 T2DM 及其相关并发症提供用药思路。

Abstract

The development of type2 diabetes mellitus (T2DM) is closely related to insulin resistance and pancreatic β-cell dysfunction, and high mobility group box 1 (HMGB1) and its related receptors and signaling pathways play an important role in the development of T2DM and its complications. HMGB1 is a core regulator of inflammatory response, widely found in various tissues and organs such as liver, adipose, skeletal muscle, and pancreatic islets, and affects the course of T2DM by enhancing inflammatory response and exacerbating insulin resistance. In recent years, a variety of traditional Chinese medicines (TCM) have been shown to slow down the progression of T2DM and its complications by regulating the expression of HMGB1 and its related receptors and signaling pathways. Therefore, the article discusses the current status of domestic and international research on the intervention of Chinese medicines in the HMGB1 pathway to improve T2DM and its complications, with the aim of providing medication ideas for the future use of Chinese medicines in the treatment of T2DM and its related complications.

关键词

高迁移率族蛋白 B1 / 2 型糖尿病 / 中药 / 通路 / 机制

Key words

high mobility group protein B1 / type 2 diabetes mellitus / traditional Chinese medicine / pathway / mechanism

引用本文

引用格式 ▾
卢爱琳,袁梦蕊,吴永青,刘弘毅. 中药干预HMGB1通路改善2型糖尿病及其并发症的研究进展[J]. 中国临床药理学与治疗学, 2026, 31(6): 827-835 DOI:10.12092/j.issn.1009-2501.2026.06.012

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Chen R, Zou J, Zhong X, et al. HMGB1 in the interplay between autophagy and apoptosis in cancer[J].Cancer Lett, 2024, 581: 216494.

[2]

Meng Q, Ma J, Suo L, et al. Galantamine improves glycemic control and diabetic nephropathy in Leprdb/db mice[J].Sci Rep, 2023, 13(1): 15544.

[3]

Behl T, Sharma E, Sehgal A, et al. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: highlighting signalling pathways via RAGE and TLRs[J].Mol Biol Rep, 2021, 48(3): 1869-1881.

[4]

Wang Y, Zhong J, Zhang X, et al. The role of HMGB1 in the pathogenesis of type 2 diabetes[J].J Diabetes Res, 2016, 2016(1): 2543268.

[5]

唐虹, 李林霞, 华宇, 等. 茯苓酸改善多囊卵巢综合征大鼠胰岛素抵抗的作用及机制研究[J].中国药房, 2024, 35(1): 57-62.

[6]

Yang L, Zhou L, Wang X, et al. Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice[J].Int Immunopharmacol, 2020, 89(1): 106987.

[7]

亢丽娟, 董海平, 宋艳艳. 栀子苷调节 HMGB1-RAGE 信号通路对妊娠期糖尿病大鼠胰岛素抵抗的影响[J].解剖学研究, 2024, 46(2): 176-182+190.

[8]

Jiang Y, Steinle JJ.HMGB1 inhibits insulin signalling through TLR4 and RAGE in human retinal endothelial cells[J].Growth Factors, 2018, 36(3/4): 164-171.

[9]

马静, 王齐, 陈彩玲, 等. 欧前胡素调节 HMGB1-RAGE-NF-κB 信号通路对高糖诱导的视网膜内皮细胞损伤的影响[J].中国细胞生物学学报, 2024, 46(8): 1506-1514.

[10]

王雅清, 王勇, 刘永胜. 芦丁调控 miR-155 和 HMGB1/RAGE 通路对糖尿病视网膜病变大鼠炎性反应的影响[J].陕西医学杂志, 2024, 53(2): 184-188.

[11]

Hou Y, Xin M, Li Q, et al. Glycyrrhizin micelle as a genistein nanocarrier: synergistically promoting corneal epithelial wound healing through blockage of the HMGB1 signaling pathway in diabetic mice[J].Exp Eye Res, 2021, 204: 108454.

[12]

Wu B, Lin J, Luo J, et al. Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice[J].Biomed Res Int, 2017, 2017: 3764370.

[13]

潘娟, 王琪, 田艳妮. 甘草甜素调节 HMGB1/RAGE 信号通路对高糖诱导的心肌细胞凋亡和自噬的影响[J].中西医结合心脑血管病杂志, 2024, 22(11): 1961-1966.

[14]

Farrag EAE, Hammad MO, Safwat SM, et al. Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE/HMGB-1 signaling pathway[J].Sci Rep, 2023, 13(1): 11043.

[15]

Cheng M, Liu H, Zhang D, et al. HMGB1 enhances the AGE-induced expression of CTGF and TGF-β via RAGE-dependent signaling in renal tubular epithelial cells[J].Am J Nephrol, 2015, 41(3): 257-266.

[16]

Zhang H, Zhang R, Chen J, et al. High mobility group box1 inhibitor glycyrrhizic acid attenuates kidney injury in streptozotocin-induced diabetic rats[J].Kidney Blood Press Res, 2018, 42(5): 894-904.

[17]

姜一凡, 李小荣, 耿嘉逸, 等. 槲皮素通过抑制 HMGB1/RAGE/NF-κB 信号通路减轻糖尿病引起的大鼠肾脏损伤[J].南方医科大学学报, 2024, 44(9): 1769-1775.

[18]

傅永锦, 夏雪怡, 张小牧, 等. 川芎嗪对糖尿病肾病大鼠下调 HMGB1 表达及降低 RAGEs 作用[J].中国临床药理学与治疗学, 2017, 22(8): 846-851.

[19]

Abdelkader NF, Ibrahim SM, Moustafa PE, et al. Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways[J].Biomed Pharmacother, 2022, 145: 112395.

[20]

Aghamiri SH, Komlakh K, Ghaffari M.Toll-like receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy[J].Int Immunopharmacol, 2022, 102: 108398.

[21]

孙跃先, 王九妹, 崔新刚, 等. 穿心莲内酯调节 HMGB1/RAGE 信号通路对糖尿病周围神经病变大鼠坐骨神经功能损伤的影响[J].中国药房, 2024, 35(5): 572-577.

[22]

Shi M, Zhang X, Zhang R, et al. Glycyrrhizic acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity[J].J Biomed Res, 2022, 36(3): 181.

[23]

郑领涛, 申妍姣, 宋丽明. 连翘苷抑制 HMGB1/RAGE 信号通路减轻大鼠糖尿病周围神经病变坐骨神经损伤[J].免疫学杂志, 2024, 40(1): 46-52.

[24]

Škrha Jr J, Kalousova M, Švarcová J, et al. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus[J].Exp Clin Endocrinol Diabetes, 2012, 120(5): 277-281.

[25]

Otoo A, Czika A, Lamptey J, et al. Emodin improves glucose metabolism and ovarian function in PCOS mice via the HMGB1/TLR4/NF-κB molecular pathway[J].Reproduction, 2023, 166(5): 323-336.

[26]

Zhao H, Zhang J, Yu J.HMGB-1 as a potential target for the treatment of diabetic retinopathy[J].Med Sci Monit Int Med J Exp Clin Res, 2015, 21: 3062.

[27]

Jiang S, Chen X.HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo[J].Drug Des Devel Ther, 2017, 11: 783-795.

[28]

孟宏, 王桂青, 杜竹君. 西红花苷通过调控 TLR4/MyD88/NF-κB 通路改善糖尿病大鼠视网膜病变机制研究[J].陕西医学杂志, 2023, 52(5): 531-535+540.

[29]

高明, 徐丽丽, 王利存, 等. 基于 TLR4/NF-κB 信号通路探讨银杏二萜内酯对糖尿病大鼠视网膜病变的影响[J].天津中医药, 2023, 40(5): 654-661.

[30]

朱素华. 芍药苷抑制糖尿病视网膜病变基质金属蛋白酶 9 激活的研究[D].南京:南京医科大学, 2017.

[31]

Tao A, Song J, Lan T, et al. Cardiomyocyte-fibroblast interaction contributes to diabetic cardiomyopathy in mice: role of HMGB1/TLR4/IL-33 axis[J].Biochim Biophys Acta Mol Basis Dis, 2015, 1852(10): 2075-2085.

[32]

孟昭昀, 张燕群, 王秀玲, 等. 桂皮醛调控 HMGB1/TLR4/NF-κB 通路对糖尿病心肌病大鼠的心肌保护作用研究[J].中药材, 2024, (4): 989-992.

[33]

Zhu Z, Hu X. HMGB1 induced endothelial permeability promotes myocardial fibrosis in diabetic cardiomyopathy[J].Int J Cardiol, 2017, 227: 875.

[34]

Mudaliar H, Pollock C, Komala MG, et al. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules[J].Am J Physiol Renal Physiol, 2013, 305(2): F143-F154.

[35]

Huang L, Lin T, Shi M, et al. Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease[J].Am J Physiol Regul Integr Comp Physiol, 2024, 327(4): R410-R422.

[36]

边咏馨. 牛磺酸对糖尿病肾病预防作用的研究[D].沈阳:沈阳农业大学, 2020.

[37]

Zhou B, Li Q, Wang J, et al. Ellagic acid attenuates streptozocin induced diabetic nephropathy via the regulation of oxidative stress and inflammatory signaling[J].Food Chem Toxicol, 2019, 123: 16-27.

[38]

熊刚, 邹华, 胡承莲, 等. 基于 HMGB1/TLR4 信号通路评价五味子乙素对 2 型糖尿病肾病大鼠肾脏功能的保护作用[J].医学研究杂志, 2019, 48(3): 140-143.

[39]

Liu ZZ, Weng HB, Zhang LJ, et al. Bupleurum polysaccharides ameliorated renal injury in diabetic mice associated with suppression of HMGB1-TLR4 signaling[J].Chin J Nat Med, 2019, 17(9): 641-649.

[40]

何流, 金智生, 张磊, 等. 红芪多糖对糖尿病周围神经病变 ob/ob 小鼠高迁移率族蛋白 1-Toll 样受体 4 信号通路的影响[J].中国临床药理学杂志, 2019, 35(7): 657-660.

[41]

Zhang C, Hu J, Wang W, et al. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS[J].FASEB J, 2020, 34(7): 9563-9574.

[42]

许月娇. 香青兰总黄酮对 T2DM 大鼠胰岛功能的影响及作用机制研究[J].湖北科技学院学报 (医学版), 2021, 35(6): 465-468+474+456.

[43]

Yan X, Xu P, Zhou L, et al. Blockade of high mobility group box 1 involved in the protective of curcumin on myocardial injury in diabetes in vivo and in vitro[J].IUBMB life, 2020, 72(5): 931-941.

[44]

Liu B, Li S, Sui X, et al. Root extract of Polygonum cuspidatum Siebold & Zucc. ameliorates DSS-induced ulcerative colitis by affecting NF-kappaB signaling pathway in a mouse model via synergistic effects of polydatin, resveratrol, and emodin[J].Front Pharmacol, 2018, 9: 347.

[45]

袁小波, 彭小珊, 周丽丽, 等. 荞麦黄酮通过下调 HMGB1 抑制高糖诱导的人视网膜微血管内皮细胞损伤的研究[J].中国免疫学杂志, 2023, 39(11): 2311-2317.

[46]

尹延航, 陈绪才, 王益, 等. 芒果苷通过 Nrf-2/HO-1/HMGB1/NF-κB 通路减轻链脲佐菌素诱导的大鼠视网膜病变的机制探讨[J].中国社区医师, 2023, 39(1): 12-14.

[47]

凌佼佼, 栾兰, 杨芳, 等. 葛花总黄酮对链脲佐菌素诱导糖尿病视网膜病变小鼠玻璃体血管内皮生长因子及高迁移率族蛋白 B1 信号通路的影响[J].中国医院用药评价与分析, 2020, 20(7): 812-816.

[48]

韦艳, 李红, 苏晓庆, 等. 白藜芦醇对高糖环境下视网膜血管内皮细胞增殖及 HMGB1 乙酰化的影响[J]. 国际眼科杂志, 2015, 15(12): 2049-2051.

[49]

Song J, Liu Q, Tang H, et al. Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment[J].Oncotarget, 2016, 7(49): 80803.

[50]

Chen J, Ye X, Yan T, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats[J].Stroke, 2011, 42(12): 3551-3558.

[51]

Zhang H, Morgan B, Potter BJ, et al. Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging[J].Am J Physiol Heart Circ Physiol, 2010, 299(4): H985-H994.

[52]

Wang WK, Lu QH, Zhang JN, et al. HMGB 1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway[J].J Cell Mol Med, 2014, 18(11): 2311-2320.

[53]

刘思妤, 刘青, 彭群龙, 等. 二氢杨梅素通过抑制 HMGB1 改善糖尿病大鼠心功能不全[J].南方医科大学学报, 2022, 42(5): 641-648.

[54]

Wu K, Zha H, Wu T, et al. Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway[J].Cell Mol Life Sci, 2024, 81(1): 1-15.

[55]

Jin J, Gong J, Zhao L, et al. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux[J].J Diabetes, 2019, 11(10): 826-836.

[56]

马洪海. 黄芪甲苷纳米混悬剂的制备与评价及对糖尿病肾病的治疗[D].哈尔滨:哈尔滨商业大学, 2021.

[57]

谢莹, 林鑫, 袁静, 等. 毛蕊花糖苷对糖尿病肾病小鼠肾组织中高迁移率族蛋白 1 及核因子 κB 表达的影响[J].中华肾脏病杂志, 2021, 37(10): 817-823.

[58]

Zhang FF, Morioka N, Harano S, et al. Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloprotease-9 up-regulation in mice with painful peripheral neuropathy[J].J Neurochem, 2016, 136(4): 837-850.

[59]

Zhao X, Shen L, Xu L, et al. Inhibition of CaMKIV relieves streptozotocin-induced diabetic neuropathic pain through regulation of HMGB1[J].BMC Anesthesiol, 2015, 16(1): 1-8.

[60]

Chen Q, Wang ZY, Chen LY, et al. Roles of high mobility group box 1 in cardiovascular calcification[J].Cell Physiol Biochem, 2017, 42(2): 427-440.

基金资助

国家自然科学基金-地区科学基金项目(82360919)

云南科技厅中医联合面上项目(202301AZ070001-066)

云南省卫健委高层次中医药人才培养工作项目()

AI Summary AI Mindmap
PDF (1174KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉